SEC Form 4 · accession 0002091053-26-000005
Evommune, Inc. · EVMN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janice Suzann Drew
Officer — Chief of Dev. Operations
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 8:00 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0002044725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2026 | M | 3,839 | $3.84 | A | 71,633 | D | |
| Common Stock | Jun 22, 2026 | M | 16,161 | $2.99 | A | 87,794 | D | |
| Common StockF2 | Jun 22, 2026 | S | 20,000 | $22.63 | D | 67,794 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $3.84 | Jun 22, 2026 | M | 3,839 | D | — | May 11, 2033 | Common Stock | 3,839 | 53,795 | D |
| Employee Stock Option (Right to Buy)F3 | $2.99 | Jun 22, 2026 | M | 16,161 | D | — | Dec 8, 2034 | Common Stock | 16,161 | 39,321 | D |
Explanation of responses
- F1The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2026.
- F2The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $22.50 to $23.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F3One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.